We are live on ! Find out more
CVS icon

CVS Health
CVS

1,270 hedge funds and large institutions have $74.3B invested in CVS Health in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 456 increasing their positions, 562 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 45

41% more call options, than puts

Call options by funds: $246M | Put options by funds: $175M

3% more funds holding

Funds holding: 1,236 → 1,270 (+34)

0.41% less ownership

Funds ownership: 84.33% → 83.93% (-0.41%)

1% less capital invested

Capital invested by funds: $74.9B → $74.3B (-$596M)

14% less funds holding in top 10

Funds holding in top 10: 141 → 121 (-20)

19% less repeat investments, than reductions

Existing positions increased: 456 | Existing positions reduced: 562

Holders
1,270
Holders Change
+34
Holders Change %
+2.75%
% of All Funds
36.49%
Holding in Top 10
121
Holding in Top 10 Change
-20
Holding in Top 10 Change %
-14.18%
% of All Funds
3.48%
New
86
Increased
456
Reduced
562
Closed
45
Calls
$246M
Puts
$175M
Net Calls
+$71M
Net Calls Change
+$55.6M

Top Buyers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
+$716M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$249M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$190M
4
JP Morgan Chase
JP Morgan Chase
New York
+$161M
5
Capital World Investors
Capital World Investors
California
+$122M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$1.01B
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$344M
3
Lazard Asset Management
Lazard Asset Management
New York
-$240M
4
DSA
Davis Selected Advisers
Arizona
-$183M
5
VAM
Visium Asset Management
New York
-$122M
Name Holding Trade Value Shares
Change 		Change in
Stake
KS
851
Karpas Strategies
Connecticut
$1.28M – – –
BOS
852
Bank of Stockton
California
$1.27M -$17.4K -230 -1%
MIU
853
Man Investments (UK)
United Kingdom
$1.25M -$899K -11,895 -42%
FSC
854
Fiduciary Services Corp
Georgia
$1.25M +$70.3K +930 +6%
WC
855
Wexford Capital
Florida
$1.24M +$110K +1,450 +10%
KC
856
Kingfisher Capital
North Carolina
$1.24M +$1.24M +16,426 New
SCM
857
Schnieders Capital Management
California
$1.24M +$605K +8,002 +95%
TAM
858
Thornmark Asset Management
Ontario, Canada
$1.23M – – –
PG
859
Proffitt & Goodson
Tennessee
$1.22M -$11K -145 -0.9%
ICAS
860
Investors Capital Advisory Services
Massachusetts
$1.21M +$318K +4,205 +35%
NMIFOAC
861
National Mutual Insurance Federation of Agricultural Cooperatives
Japan
$1.21M – – –
VAM
862
Visium Asset Management
New York
$1.2M -$122M -1,616,923 -99%
AAM
863
Azzad Asset Management
Virginia
$1.19M +$611K +8,082 +105%
SCM
864
Shelton Capital Management
Colorado
$1.18M +$408K +5,400 +53%
EP
865
Edgestream Partners
New Jersey
$1.18M +$1.18M +15,622 New
SCM
866
Sterling Capital Management
North Carolina
$1.17M +$760K +10,050 +182%
SRC
867
Shufro Rose & Co
New York
$1.17M -$60.5K -800 -5%
EB
868
Eastern Bank
Massachusetts
$1.16M -$18.9K -250 -2%
AWM
869
Altavista Wealth Management
North Carolina
$1.16M -$238K -3,148 -17%
PAG
870
Private Advisor Group
New Jersey
$1.15M +$470K +6,217 +69%
PSC
871
Prentiss Smith & Co
Vermont
$1.14M -$54.4K -720 -5%
NPC
872
National Planning Corporation
California
$1.14M +$239K +3,166 +27%
NSEDCP
873
NJ State Employees Deferred Compensation Plan
New Jersey
$1.13M – – –
WFM
874
Wilmington Funds Management
Delaware
$1.12M -$1.06M -14,090 -49%
MCM
875
Matarin Capital Management
New York
$1.12M +$535K +7,080 +92%
33 34
35
36 37

CVS Hedge Fund Activity: Q2 2014 in Review

1,270 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2014, worth a combined $74.3B — down 0.8% from $74.9B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CVS positions and 45 closed out — a net gain of 41 holders — while 456 added to existing stakes and 562 trimmed.

The largest buyer was Norges Bank, adding an estimated $716M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $1.01B sold.

  • 1,270 institutional investors held CVS Health (CVS) as of Q2 2014, up from 1,236 in Q1 2014.
  • Funds reported $74.3B of CVS Health stock for Q2 2014, down 0.8% quarter-over-quarter.
  • 86 funds opened new CVS Health positions in Q2 2014 and 45 closed out, a net change of +41 holders.
  • The largest CVS Health buyer in Q2 2014 was Norges Bank, an estimated $716M added.
  • The largest CVS Health seller in Q2 2014 was Capital Research Global Investors, an estimated $1.01B sold.

Based on aggregated 13F filings for Q2 2014.